Fisher Pharmaceuticals SRL
Fisher Pharmaceuticals reported total assets of 4,503 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jan 2026).
The score of Fisher Pharmaceuticals shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Fisher Pharmaceuticals's annual accounts
| 2025 | |
|---|---|
| Net result | 1,617 € |
| Equity | 3,617 € |
| Cash | 26 € |
| EBITDA | 3,094 € |
| Total assets | 4,503 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 30 Jan 2026
Fisher Pharmaceuticals's financial analysis
- Solvency80.3%sector median: 47.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Fisher Pharmaceuticals
Fisher Pharmaceuticals's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1016.131.517
- VAT number
- BE1016131517
- Peppol
- Registered · 0208:1016131517 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Nov 2024
- Registered office
- 1150 Woluwe-Saint-Pierre
- Latest accounts
- 2025 · filed on 30 Jan 2026
- Activity
- Non-specialised wholesale trade (NACE 46900)
Fisher Pharmaceuticals (SRL) has been based in Woluwe-Saint-Pierre since 2024, active in: non-specialised wholesale trade. For 2025, it reports a net profit of 1,617 € and equity of 3,617 €; its revenue is not published. Its solvency stands at 80.3%, above the median of its sector (47.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Fisher Pharmaceuticals
Companies in the same business, of comparable size and area, outside its group.
- Sharez Wholesale of other food Ixelles · balance sheet 92,634 €
- Helios Laboratoires Wholesale of other food Ixelles · balance sheet 169,484 €
- Giersch HO Wholesale of other food Uccle · balance sheet 229,681 €
- Brupharm Pharmalab Manufacture of pharmaceutical preparations Mons · balance sheet 298,430 €
- SoBiVet Wholesale of other food Kortenberg · balance sheet 107,925 €
- Alexion Services Europe Wholesale of pharmaceutical and medical goods Brussels · balance sheet 776,084 €
- Moleac Belgium Wholesale of pharmaceutical and medical goods Auderghem · balance sheet €1.79m
- Laboratoires Forte Pharma Benelux Wholesale of other food Brussels · balance sheet €1.85m
Frequently asked questions about Fisher Pharmaceuticals
What is the revenue of Fisher Pharmaceuticals?
Fisher Pharmaceuticals files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Fisher Pharmaceuticals?
In Belgium, the VAT number is the company number prefixed with BE: BE1016131517 for Fisher Pharmaceuticals, if the company is VAT-registered. Its company number (CBE) is 1016.131.517.
Where is the registered office of Fisher Pharmaceuticals?
According to the CBE register, the registered office of Fisher Pharmaceuticals is in 1150 Woluwe-Saint-Pierre.
What is the equity of Fisher Pharmaceuticals?
At the close of the 2025 financial year, the equity of Fisher Pharmaceuticals amounts to 3,617 €, a solvency of 80.3% of total assets.
Who manages Fisher Pharmaceuticals?
The register lists 1 active mandates at Fisher Pharmaceuticals. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Fisher Pharmaceuticals
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →